Brickell Biotech, Inc. (FRTX) Misses Q3 EPS by 64c

Brickell Biotech, Inc. (NASDAQ: FRTX) reported Q3 EPS of ($2.07), $0.64 worse than the analyst estimate of ($1.43). Revenue for the quarter came in at $486 thousand versus the consensus estimate of $206.67 thousand.

For earnings history and earnings-related data on Brickell Biotech, Inc. (FRTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c